[144] NuSkin Enterprises, Inc. SEC Filing

Rhea-AI Filing Summary

Nu Skin Enterprises (NUS) filing a Form 144 notifies the SEC of a proposed sale of 20,000 Class A shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $239,433.56 and approximately 49,497,715 Class A shares outstanding. The securities listed were acquired as restricted stock vesting from the issuer on multiple dates between 02/15/2022 and 02/15/2024, with individual lot sizes shown. The filer reports no securities sold in the past three months and affirms they possess no undisclosed material adverse information about the issuer. The notice includes required signature and legal attestation language.

Positive

• Transparent compliance: The filer provided required Form 144 details including broker, share count, aggregate value, and acquisition history.
• No recent sales: The filer reports "Nothing to Report" for securities sold in the past three months, reducing ambiguity about recent insider selling.

Negative

• Insider sale proposed: The notice indicates a proposed sale of 20,000 Class A shares, which could be perceived negatively by some investors despite its small size relative to outstanding shares.

Insights

Securities Analyst

TL;DR Proposed sale is small relative to outstanding shares and stems from routine vested compensation.

The Form 144 shows a proposed transaction of 20,000 Class A shares valued at $239,433.56 to be executed through Fidelity on the NYSE. All reported lots were acquired via restricted stock vesting as compensation across 2022–2024, indicating these shares originated from granted awards rather than open-market purchases. No sales in the past three months are reported, which reduces near-term liquidity signal noise. The filing represents compliance with required insider sale notification rules but does not by itself indicate material corporate change.

Corporate Governance Expert

TL;DR Filing is a routine insider-sale notice with standard attestations; impact appears neutral.

The disclosure meets Rule 144 notice requirements and includes the filer’s representation about lack of undisclosed material adverse information. The acquisition history details multiple vested restricted stock events, showing the shares are compensatory in nature. Absent other disclosures (e.g., a trading plan date or concurrent material events), this Form 144 is a routine governance compliance document rather than an indicator of governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20000	239433.56	49497715	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/15/2022	Restricted Stock Vesting	Issuer			1756	02/15/2022	Compensation
Class A	06/05/2022	Restricted Stock Vesting	Issuer			1564	06/05/2022	Compensation
Class A	08/01/2022	Restricted Stock Vesting	Issuer			329	08/01/2022	Compensation
Class A	02/15/2023	Restricted Stock Vesting	Issuer			3061	02/15/2023	Compensation
Class A	06/05/2023	Restricted Stock Vesting	Issuer			1234	06/05/2023	Compensation
Class A	08/01/2023	Restricted Stock Vesting	Issuer			260	08/01/2023	Compensation
Class A	12/20/2023	Restricted Stock Vesting	Issuer			11542	12/20/2023	Compensation
Class A	02/15/2024	Restricted Stock Vesting	Issuer			254	02/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Nu Skin (NUS) Form 144 disclose?

It discloses a proposed sale of 20,000 Class A shares via Fidelity on the NYSE with an aggregate market value of $239,433.56.

How were the shares being sold by the NUS filer acquired?

All listed shares were acquired through restricted stock vesting from the issuer on various dates between 02/15/2022 and 02/15/2024 as compensation.

Does the filing report recent insider sales for NUS?

No. The filing indicates "Nothing to Report" for securities sold during the past three months.

What broker and exchange will handle the proposed sale?

The broker is Fidelity Brokerage Services LLC and the sale is to occur on the NYSE.

What percentage of outstanding shares does the proposed sale represent?

The proposed 20,000 shares represent approximately 0.04% of the reported 49,497,715 Class A shares outstanding.